DyDo Group Holdings, Inc.

Equities

2590

JP3488400007

Non-Alcoholic Beverages

Delayed Japan Exchange 10:30:00 2024-04-23 pm EDT 5-day change 1st Jan Change
2,690 JPY -0.59% Intraday chart for DyDo Group Holdings, Inc. +2.99% -8.03%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
DyDo Group Disposes 17.67 Million Worth of Shares as Restricted Stock Compensation MT
DyDo Sets Up Nominating and Compensation Committee MT
DyDo Group Holdings, Inc. Announces Committee Changes CI
DyDo Group Holdings to Book 4.5 Billion Yen From Gain on Sale of Investment MT
DyDo Group Holdings, Inc. Reports Sales Results for the Month from February 21, 2024 to March 20, 2024 and Year to Date from January 21, 2024 to March 20, 2024 CI
DyDo Group Holdings, Inc. Provides Dividend Guidance for the Full Year Ending January 2025 CI
DyDo Group Holdings, Inc. Provides Dividend Guidance for the Second Quarter of 2025 CI
DyDo Group Holdings, Inc. Announces Dividend for the Fiscal Year Ended January 20, 2024, Payable on April 17, 2024 CI
DyDo Group Holdings, Inc. Reports Monthly Sales Results for the Month from January 21, 2024 to February 20, 2024 CI
DyDo Group Holdings, Inc. completed the acquisition of WOSANA S.A. from Avallon MBO II managed by Avallon Sp. z o.o. CI
Dydo Group Holdings, Inc. Revises Consolidated Financial Forecasts for the Year Ending January 20, 2024 CI
DyDo Group Holdings, Inc. Reports Sales Results for the Month from December 21, 2023 to January 20, 2024 and Year to Date from January 21, 2023 to January 20, 2024 CI
Dydo's Sales Gains 29.2% in Final Two Months of Fiscal Year MT
DyDo Group Holdings, Inc. Reports Sales Results for the Month from November 21, 2023 to December 20, 2023 and Year to Date from January 21, 2023 to December 20, 2023 CI
DyDo Group to Acquire Polish Soft Drink Manufacturer for Over 7 Billion Yen MT
DyDo Group Holdings, Inc. signed an agreement to acquire WOSANA S.A. for PLN 197.58 million. CI
Dydo Group Unit Files New Drug Application for Autoimmune Disease Treatment Candidate MT
Catalyst Pharmaceuticals Partner Submits New Drug Application for Neuromuscular Disorder Treatment in Japan MT
DyDo Group Holdings, Inc. Reports Sales Results for the Month from October 21, 2023 to November 20, 2023 and Year to Date from January 21, 2023 to November 20, 2023 CI
DyDo Group Holdings, Inc. Provides Dividend Guidance for the Year Ending January 2024 CI
DyDo Group Holdings, Inc. Provides Consolidated Earnings Guidance for the Year Ending January 2024 CI
DyDo Group Holdings, Inc. Announces Preliminary Sales Results for the Month and Year to Date Ended October 20, 2023 CI
DyDo Group Holdings, Inc. Announces Sales Results for the Month and Year to Date Ended August 20, 2023 CI
DyDo Group Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending January 20, 2024 CI
DyDo Group Holdings, Inc. Announces Dividend for the Second Quarter Ended July 2023, Payable on September 21, 2023; Provides Dividend Guidance for the Full Year Ending January 2024 CI
Chart DyDo Group Holdings, Inc.
More charts
DyDo Group Holdings, Inc., formerly DyDo DRINCO, INC. is a Japan-based company mainly engaged in the manufacture and sale of beverages. The Company operates through three business segments. The Beverage Sales segment is involved in the planning, development and sale of various soft drinks to consumers through convenience stores and vending machines. Through a consolidated subsidiary, this segment is also engaged in the manufacture and sale of drinkable preparations such as quasi drugs. The Contract Drink Manufacturing segment is engaged in the contract manufacture of drinkable preparations, including drugs and medicines, quasi drugs, as well as soft drinks. The Foods Manufacture and Sale segment is involved in the manufacture and sale of fruit jellies.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
2,706 JPY
Average target price
3,000 JPY
Spread / Average Target
+10.86%
Consensus